By
34 min ago 2 min read
Italian industrial gas firm SOL Group reported a 10.4% increase in sales to €1.45bn ($1.6bn) during the first nine months of 2026, amid continued expansion of its international operations.
Revenue in the July to September period reached €498.9m ($553.8m), up 14% year-on-year, as the group continued to expand its international operations despite challenging industrial market conditions.
SOL’s technical gases business generated €714.1m ($792.7m) in sales over the nine months, an increase of 7.7%. The firm reported new customer wins and market share gains against a backdrop of uneven industrial recovery and volatile energy costs.
Its Vivisol home medical care division grew faster, with revenue rising 12.6% to €764.3m ($848.5m), supported by increasing patient numbers and acquisitions.
International markets continued to outpace SOL’s domestic business, with sales outside Italy rising 11.3% to €902.9m ($1bn) compared with 8.8% growth to €544.5m ($604.5m) in Italy.
It comes after the company in Brazilian industrial gas firm Industria Brasileria de Gases (IBG) at the end of July, adding to an established production and distribution network to its operations.
The acquisition formed part of a broader international expansion programme spanning Europe and South America, with SOL also acquiring Denmark’s in Q3 and Polish medical services firm .
SOL Vice-President Marco Annoni said the firm’s revenue growth and targeted expansions showed the firm’s “responsiveness and competitive strength” despite an “overall economic environment that remains uneven.”
The company expects sales momentum to continue into the final quarter.
